GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Soligenix Inc (NAS:SNGX) » Definitions » E10

Soligenix (Soligenix) E10 : $-390.10 (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Soligenix E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Soligenix's adjusted earnings per share data for the three months ended in Mar. 2024 was $-2.880. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-390.10 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 14.00% per year. During the past 5 years, the average E10 Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Soligenix was 37.10% per year. The lowest was 11.50% per year. And the median was 20.60% per year.

As of today (2024-06-09), Soligenix's current stock price is $3.78. Soligenix's E10 for the quarter that ended in Mar. 2024 was $-390.10. Soligenix's Shiller PE Ratio of today is .


Soligenix E10 Historical Data

The historical data trend for Soligenix's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Soligenix E10 Chart

Soligenix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -873.31 -687.31 -672.12 -605.86 -437.16

Soligenix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -584.82 -501.46 -396.12 -437.16 -390.10

Competitive Comparison of Soligenix's E10

For the Biotechnology subindustry, Soligenix's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Soligenix's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Soligenix's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Soligenix's Shiller PE Ratio falls into.



Soligenix E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Soligenix's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-2.88/131.7762*131.7762
=-2.880

Current CPI (Mar. 2024) = 131.7762.

Soligenix Quarterly Data

per share eps CPI Adj_EPS
201406 -120.000 100.560 -157.252
201409 -504.000 100.428 -661.323
201412 0.000 99.070 0.000
201503 -456.000 99.621 -603.185
201506 -360.000 100.684 -471.172
201509 -108.000 100.392 -141.763
201512 -177.600 99.792 -234.521
201603 -141.600 100.470 -185.721
201606 -45.600 101.688 -59.092
201609 -117.600 101.861 -152.138
201612 -33.600 101.863 -43.467
201703 -76.800 102.862 -98.388
201706 -98.400 103.349 -125.466
201709 -40.800 104.136 -51.629
201712 -64.800 104.011 -82.098
201803 -64.800 105.290 -81.101
201806 -43.200 106.317 -53.545
201809 -26.400 106.507 -32.664
201812 -43.200 105.998 -53.706
201903 -21.600 107.251 -26.539
201906 -28.800 108.070 -35.118
201909 -33.600 108.329 -40.872
201912 -33.600 108.420 -40.838
202003 -76.800 108.902 -92.932
202006 -24.000 108.767 -29.077
202009 -14.400 109.815 -17.280
202012 -45.600 109.897 -54.679
202103 -15.400 111.754 -18.159
202106 -12.000 114.631 -13.795
202109 -21.600 115.734 -24.594
202112 -19.536 117.630 -21.885
202203 -24.320 121.301 -26.420
202206 -13.280 125.017 -13.998
202209 -18.400 125.227 -19.362
202212 -20.960 125.222 -22.057
202303 -5.760 127.348 -5.960
202306 -3.520 128.729 -3.603
202309 -2.560 129.860 -2.598
202312 -2.560 129.419 -2.607
202403 -2.880 131.776 -2.880

Add all the adjusted EPS together and divide 10 will get our e10.


Soligenix  (NAS:SNGX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Soligenix E10 Related Terms

Thank you for viewing the detailed overview of Soligenix's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Soligenix (Soligenix) Business Description

Traded in Other Exchanges
Address
29 Emmons Drive, Suite B-10, Princeton, NJ, USA, 08540
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
Executives
Timothy R. Cote director 3529 TILDEN STREET, NW, WASHINGTON DC 20008
Richard Straube officer: CMO 29 EMMONS DRIVE, SUITE C-10, PRINCETON NJ 08540
Christopher Schaber director, officer: Chairman, CEO and President 29 EMMONS DRIVE, SUITE C-10, PRINCETON NJ 08540
Jonathan L. Guarino officer: Chief Financial Officer 100 WELLESLEY WAY, FREEHOLD NJ 07728
Oreola Donini officer: CSO 29 EMMONS DRIVE, SUITE C-10, PRINCETON NJ 08540
Robert J. Rubin director 7901 SPRINGER ROAD, BETHESDA MD 20817
Anthony Gregg Lapointe director PO BOX 83216, GAITHERSBURG MD 20883-3216
Diane L. Parks director 29 EMMONS DRIVE, SUITE B-10, PRINCETON NJ 08540
Jerome B Zeldis director 8767 E. VIA DE VENTURA, SUITE 190, SCOTTSDALE AZ 85258
Mark E. Pearson director, 10 percent owner 3031 TISCH WAY, SUITE 505, SAN JOSE CA 95128
Preta Martina Cavazza other: Former 10% Owner VIA SUDAFRICA 20, ROME L6 00144
Enrico Cavazza other: Former 10% Owner VIA PONTINA KM 30,400, POMEZIA (ROME) L6 00040
Silvia Cavazza other: Former 10% Owner VIA PONTINA KM 30,400, POMEZIA (ROME) L6 00040
Francesca Cavazza other: Former 10% Owner VIA PONTINA KM 30,400, POMEZIA (ROME) L6 00040
Spa Essetifin 10 percent owner VIA SUDAFRICA 20, ROME L6 00144